Bnp Paribas Asset Management Holding S.A. Charles River Laboratories International, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 4,615 shares of CRL stock, worth $493,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,615
Previous 142,426
96.76%
Holding current value
$493,297
Previous $28.1 Million
96.96%
% of portfolio
0.0%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding CRL
# of Institutions
700Shares Held
50.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$658 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$544 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$233 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$193 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$193 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.44B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...